MedTechnology
By
Is Thermo Fisher’s $10B Q2 Surge the Inflection Point for AI-Powered Biopharma? How Will It Reshape the Life Sciences Landscape?
Key Highlights Financial Resilience and Strategic MarginsThermo Fisher Scientific’s Q2 2025 report showcases its fortress-like financial discipline. With…
Can IGC Pharma’s New AI Models Change Alzheimer’s Diagnosis and Drug Discovery for Millions?
New tools unveiled at AAIC 2025 aim to detect Alzheimer’s earlier and faster, even in low-resource settings Key…
Is Ochsner Health’s AI Strategy a Blueprint for Ethical, Effective Physician Support?
Key Highlights Physicians Demand Responsible AIAn AMA survey of nearly 1,200 physicians revealed strong consensus on AI expectations:…
FDA clears Felix NeuroAI, the first AI-powered noninvasive wristband for essential tremor relief for 7 Million Patients
Key Takeaways FDA Clears First AI-Driven Wristband for Essential TremorFasikl’s Felix NeuroAI Wristband has received 510(k) clearance from…
Is Aptitude’s $9M BARDA Partnership and Metrix Filovirus Panel the Breakthrough for Fast, Decentralized Detection of Ebolavirus and Marburgvirus?
Key Highlights BARDA Partnership Accelerates Filovirus Diagnostic InnovationAptitude’s second collaboration with BARDA brings $9 million in new federal…
Is Aidoc’s $150M Bet on CARE™ and aiOS™ Resetting the Future of Clinical AI for 100 Million Patients?
Key Highlights CARE™ Foundation Model Redefining Standards in Clinical AIAidoc’s CARE™ model—now backed by $150 million in new…
